IMPROVING OUTCOMES
IN ORTHOPEDIC SURGERY

through proprietary devices that enable direct antibiotic treatment of infected joints

About Us

The Challenge

Periprosthetic Joint Infection (PJI) is devastating to patient health, frustrating to surgeons, and costly to the healthcare system.  


PJI presents as Acute, Chronic or Hematogenous.  This is a growing problem.  Without infection control improvement, the estimated WW treatment cost in 2020 is $1.6B.

Our Mission

ForCast Orthopedics is improving orthopedic surgical outcomes through proprietary total joint arthroplasty devices that enable direct antibiotic treatment of joints for remediation of infection whenever it occurs     

Executive Summary

Click on a file to download.

Contact Us

Forcast Orthopedics